Publications by authors named "Tomasz Iwanowski"
Article Synopsis
- * The exact cause of vitiligo is not fully understood, but several theories exist, including genetic predisposition and immune system involvement, particularly through T lymphocytes.
- * Recent advancements in treatment options include topical and oral medications like Janus kinase inhibitors and prostaglandins, with ongoing research aiming to develop more effective therapies based on genetic studies.
Introduction: Vitiligo is an acquired chronic depigmenting disorder of the skin, predominantly asymptomatic. Although vitiligo does not cause direct physical impairment, it is commonly believed that it can produce an important psychosocial burden.
Aim: To translate, cross-culturally adapt and validate the vitiligo-specific health-related quality of life instrument (VitiQoL) into Polish.
Efficacy, quality of life, and safety of methotrexate versus interferon in head-to-head treatment in advanced stages of mycosis fungoides and Sezary syndrome. Prospective trial (NCT02323659).
Postepy Dermatol Alergol
April 2021
Introduction: ESMO guidelines recommend interferon (IFN) and methotrexate (MTX) as first-line systemic therapies in mycosis fungoides (MF) and Sezary syndrome (SS).
Aim: A prospective, head-to-head trial comparing the efficacy and safety of INF-α and MTX as first-line treatment in MF/SS patients.
Material And Methods: Forty-three patients were enrolled in the trial.
Introduction: There are many surgical methods for vitiligo treatment that have been used for over 30 years. Suction blister epidermal grafting (SBEG) is considered one of the simplest and most effective of them.
Aim: To determine how effective suction blister grafts with concomitant phototherapy are in vitiligo treatment.